ArticleCancer medicine2024

The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study.

Deniz Can Guven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.